XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.25.3

INVESTMENTS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Investments, All Other Investments [Abstract] |
Schedule of Cash and Financial Assets Measured at Fair Value on a Recurring Basis | The following tables present the Company’s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):
| September 30, 2025
| Cost |  | Unrealized Gains |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents, excluding money market accounts | $ | 82,584 |  | $ | — |  | $ | — |  | $ | 82,584 |  | $ | 82,584 |  | $ | —
Level 1: |  |  |  |  |  |  |  |  |  |  |
Money market accounts | 16,942 |  | — |  | — |  | 16,942 |  | 16,942 |  | —
Government & agency securities | 32,095 |  | 115 |  | 77 |  | 32,287 |  | — |  | 32,287
| 49,037 |  | 115 |  | 77 |  | 49,229 |  | 16,942 |  | 32,287
Level 2: |  |  |  |  |  |  |  |  |  |  |
Corporate bonds | 41,191 |  | 179 |  | 329 |  | 41,699 |  | — |  | 41,699
Total | $ | 172,812 |  | $ | 294 |  | $ | 406 |  | $ | 173,512 |  | $ | 99,526 |  | $ | 73,986
| December 31, 2024
| Cost |  | Unrealized Gains (Losses) |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents, excluding money market accounts | $ | 77,551 |  | $ | — |  | $ | — |  | $ | 77,551 |  | $ | 77,551 |  | $ | —
Level 1: |  |  |  |  |  |  |  |  |  |  |
Money market accounts | 13,377 |  | — |  | — |  | 13,377 |  | 13,377 |  | —
Government & agency securities | 28,920 |  | 15 |  | 96 |  | 29,031 |  | — |  | 29,031
Equity securities | 10,000 |  | (3,939) |  | — |  | 6,061 |  | — |  | 6,061
| 52,297 |  | (3,924) |  | 96 |  | 48,469 |  | 13,377 |  | 35,092
Level 2: |  |  |  |  |  |  |  |  |  |  |
Corporate bonds | 35,771 |  | 227 |  | 326 |  | 36,324 |  | — |  | 36,324
Total | $ | 165,619 |  | $ | (3,697) |  | $ | 422 |  | $ | 162,344 |  | $ | 90,928 |  | $ | 71,416
Schedule of Investment Losses | The gains and losses related to the Company’s LifeMD investment for the three and nine months ended September 30, 2025 and 2024 are summarized in the table below (in thousands):
| Three months ended September 30, |  |
| 2025 |  | 2024 |  |
Net losses recognized during the period on equity securities | $ | — |  |  | $ | (1,984) |  |  |
Less: Net losses recognized on equity securities sold | — |  |  | — |  |  |
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date | $ | — |  |  | $ | (1,984) |  |  |
| Nine months ended September 30,
| 2025 |  | 2024
Net gains (losses) recognized during the period on equity securities | $ | 3,222 |  |  | $ | (3,734) |
Less: Net gains recognized on equity securities sold | 3,222 |  |  | — |
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date | $ | — |  |  | $ | (3,734) |

X
- Definition Tabular disclosure of realized and unrealized gain (loss) on investment in security. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(9)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(7)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_GainLossOnInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration